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A cystcinc prolcnsc inhibitor was puriticd from total mcmbnrrc fmctlonr of an invasive mu& hcpatoma, Hcpa cl 9. On gtl filtration under 
noneeducing conditions thr puriflcd inhibitor was elu~cd in u Anglo peak of M, l&IS kDa. but wived PI two bands at 14 and 70 kDa on 
SDS-PAGE under reducing conditions. By isoclcctric focusing. the inhibitor ran ZII nn isoclcctric point oT4.75. lmmunoblotrin~ rtudics using the 
cnhzlnccd chcmilumincscsncc technique indisatcd no crossrcuctivily with monoslonul antibodia to stcfin I3 und cyrtrtin C or with a polyclonal 
antibody to low hi, kininogcn. in contrast, the 14 LDP and 70 kDa bundr both crossrcactcd with a polyclonul rntibc4y to orcfn A. sulguring 
tht the rystcine prorcrrr inhibitor ursctciutcd with Hcpa cl 9 mcmbranrs mny bc LL modified form of wtcfin A. 
Cystcioc protusc inhibitor: Cystetin: Stclin; Tumor 
1, f NTRODUCTION 
tncrmcd activity of cystcinc protcoscs in tumors has 
been shown to correspond in some ctlscs to dccrcllscd 
rcgulution by cysttrtins, protein inhibitors of cystcinc 
protctrscs [l-3]. The cystutin superfamily consists of 
tight-binding astcinc erotczlsc inhibitors (CPI)s, often 
rcfcrrcd to as pseudo-irreversible. and has been subdi- 
vided into three families: stcfins. cystutins, and kininc- 
gcns (for rcvicw, see [4,5)). The stcfins are primarily 
intrnccllular cytosolic proteins. whc:cas the cystatins 
arc sccrctcd. Stcfins arc further subdivided into stcfins 
A with acidic pIs and stcfins B with neutral pto. The pls 
for cystatin C arc in the alkaline range, Hiwasa ct al. [6] 
have suggcstcd that ~21, the mcmbrrrnc-associated c- 
Hu-rtis gene product, is a mcmbcr of the cystcltin supcr- 
family. Since WC had obscrvcd CPI activity in mcm- 
branc fractions of tumors [3]. WC have purified this CPI 
from total membrnnc fractions of en invasive murinc 
hepatomo, for comparison with other cystntins, 
2. MATERIALS AND METHODS 
CHAPS ~3~[(3cholumidopropyl)~dImcthyl~mino]~l~propanc~~ul~ 
fonatc). E-64 (~~rrunr~cpoxyru~inyl~lcucylamido[4~g~nidino]bu- 
tune), und l3rij.35 wcrc purchnscd from Sigma (St. Louis, MO, USA). 
Polyclonul and monoclonul untibodics against human cyrtatin C us 
well us rscombinont human cystatin C wcrc gifts from Dr. M. Abra- 
hamron, Univcrrity of Lund. Lund, Swcdcn. Polyclanal antibody 
against rat cgidcrmal Win A was a gift from Dr. Fukuyamn. Univcr. 
~orrrspottrfrrrce u&ircss: B.F. Sloane, rjcpurtmcnt ai Phnrmawlogy, 
Wayne Slulc Univcrrity, Detroit, MI 4820, USA. Fux: (I) (313) 577 
6739, 
rity of Californiu, San Francisco, CA. Antiocrum to human low M, 
kininogcn WIU il gift from Dr. S, Olson, Henry Ford Hospitnl, Detroit, 
Ml. USA. Kumon stcfins A and B as well IL monacloti antibody 
against human liver stcfm B were giti from Dr. V. Turk, Josef St&n 
Instirutc. ljubljma, Slovcnia. 
2.2. Tissue 
The highly invasive hcpatoma (Hcpa cl 9) was propagated in syn- 
gcncic mrlc C57BU6J mist (Jackwn Lbontoriss, Bar Harbor, ME) 
uccording to our published pro-due 171. Briefly. tumor brci wcrc 
injcctcd subcutaneously at the left axillary region. The mitt wcrc 
ncrificcd nnd turnOn hsrvcstcd when tumor weight rcachcd rppromi- 
mutely 5 g. 
2,3.1. Prcpgration of crude mcmbmnc factions 
Approximately IO0 g of Mcpa cl 9 was homopnlzcd in 80 ml of 
dispersion solution (0.1 M NaH#‘O,, 2 mM EDTA. 0.25 M susrosc, 
I mM bcnzamidinc. pCI 7.4) in a Tckmar homogcnizcr (T&mar Co.. 
Cincinnati, OH) PI room tcmpcnturc, The homogcnatc was ccntri- 
fugcd in P Beckman L7.55 ultnccntrifugc at JS,OOO rgm for 1 hat 4.C 
utilizing u Beckman Type 35 rotor. The mcmbranc pcllc~ was wash4 
three times and rcsuspcndcd in lhr ubovc butTcr containing 0.5% 
CHAPS and rtirrcd overnight at 4%. The msmbranscxtracr was then 
ccntrifugcd as above. The rupcrnarant was ~;rvcd PI the crude msm. 
bmnc fraction and used for subscqrrrnt gurilicarion rleps. 
2.3.2. Alkaline precipitation 
The crude mcmbranc fraction was adjuotcd to pH 1 I,5 with 4 N 
NirOH and incubated at room tcmpcraturc for 2 h. The pN was 
subsequently odjustcd t@ 6.5 with 4 N HCI and the suspcnrion ccntri. 
fugcd in a Beckman J2dl ccnlrifugc at 2,860 x g for 30 min at 4.C 
ond the pcllct dimrdcd. 
2.3.3. Acetone precipitation 
An equal wolumc of prechillal acctonc (-IO’C) was added gradu. 
ally IO the above supernerant and the prccipitatc rcmova! byccntrifu. 
@lion at 2,860 K 8 as above. To the oupcrnatant was added a second - 
voiumc of chlllcd acetone and tfic rcsuiiing prccigltatc rccowc&. Tix 
pllct was rauspcndcd in IS ml of50 mM NaM,PO,, pM 6.5. I mM 
EDTA, 0,5 M N&I. containing0. I9b Erij.3S. and incubated overnight 
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at 4.C with constunt nirrin& lnsolublc prarcinr wcrc rcmovcd by 
ccnrrifusntion and the supcmarum rccovcrcd. 
2.3.4. Chromaloycrphy on u papain ullhity column 
Papain affinity rcri.9 was prcp~cd us dcwitscrl previously [?S]. The 
win wnr Added to rhcfinnl rupcrnrtunt from thcucctsnc prccipihttian 
rtcp and the suspension incuburcd overnight ~1 d*C and rubrcqucnlly 
trnnrfcrrcd to a S-ml column. The tinily column wnx cquilibmfcd 
with 70 ml of SO mM NPI&PO,, pH 6.5, 1 mM EDTA. 0.5 M N&l 
and O,l% Brij-35. Non+ciHally bound pro&ins wcrc clulcd fram 
the column in 50 mM NaH:PO, pH 6.5. I mM EDTA. 1 M N&I. 
and 0.1% Brij-35 (buffer A) ~llld &&&cd. The ms:nbmnc=x.saci;tcd 
CPI activity wasclu~J from rhccolumn in IO mM NaH:DO,, pH I 1.5, 
1 mM EDNA, 0.5 M N&I, and O,l% Brij-35 (buffer 8). Individual 
fraclionr wcrc assnycd for inhibitory uctiviry rg;rinrt papain uficr 
incubation at IOO*C for 5 min to uncouple any B;lpain-inhibitor 
complcxcr and IO inuctivatc rcridbul pupain activity that co-clukd 
from the column. Fractions wcrc pooled und lhcn conccntrucd by 
pressure dislysir. 
2.3.5. Gel fillration chromatol(mphy 
The ccnccntratcd CPI aetiviry from nffmiry chramutoyruphy was 
rpplicd to two Suprosc I? gel filrration columns in tandem in OB5 
M Tris. pH 7.5, U,lS M F&Cl, Fractions of 0.5 ml wcrc collcclcd and 
assayed for inhibitory activity ugainst papain. 
Isoclcc~ic focusing wars pcrformcd on B prcwrl Pharl System (Phur- 
mash, Pissatuway. NJ) gel, pH 4X1-6.5. und silver-Wined accordiny 
to the munuftlct urcr’s proccdurc. 
Elcctrophowir was pcrformcd in 12% polylrcrylamidc gels in Ihe 
buffer oyotcm dcssribcd by hcmmli (I I]. Proteins wcrc mmxfcrrcd 
clsctrophorclically lo nitrxcllulosc mcmbrnna in a Trrnrphx clcc- 
troblotting apparatus (Mocfcr Scientific. San Francisco, CA). The 
immunoblot procedure was pcrl’ormcd uccording to the mcthad of 
BioRad [Richmond.CA). using powdered milk us blocking agent. The 
blots wcrc dcvclopcd ecsording to Amcrrhnm’s ECL dctccdon 
method (Amcrrham, Arlington Heights, IL. USA). Multiple probing 
of the same blot8 with diffcrcnt untibodicr wns performed uccording 
to Ihc procedure of Ansrahum. 
2.6. CPC ucGvity 
fnhibitary uctivity ugtinrt the plunt cyst&c prote;lsc ppp.in Qi- 
tratcd agsinrt E-64) was dctcrmincd in u aoppd rrruy according to 
our published protctcols [2]. 
RESULTS 
WC purified a CPI from the total mcmbranc fraction 
of an invasive murinc hcpntona, Mepa cl 9, by a modi- 
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Fip. I. Aflinily (A) und gel filtration chromntogrnphy (6) of the 
mcmbrzmc-uuociaud CPL The nrrows in panel (A) depict the point 
of applintion of bufkrr A and 0, rcrpcctivcly (see section 2). Arrows 
in pnncl (8) depict point of clution of M, standards: thyroglobulin 
(670,000), y-glsbulin (I 58,000). ovulbumin (44,000). myoglobin 
(l?.OOO), vitumin O-12 (1.350), respectively. a, % inhibitory ectivily; 
O. abrorbancc ut 280 nm. The frnclionr pooled arc indicntcd by hori- 
xonrnl bnrr, 
ficution of techniques used for isolation of soluble low 
M, cystntins from human tumors [2]. The total mcm- 
branc fraction of normal murinc liver did not contain 
CPI activity. Results of a typical purification of the 
Tnblc I 
Results of a typical purilication of mcmbranc-asrocintcd cyrlcinc protcnsc inhibitor from murinc hcpstomu, Hcga ~1 9 
Protein Toial Activity Y icld Specific Aclivity PuriliWion 
(mg) (IU (%) (Wmg prolcin”) (-fold) 
Homogcnatc 1,143 1.91. WJ1 0.002 1 
Alkaline precipitation 297 1,8? 95 0.006 
Afstonc prccipitution 4s 0.24 I3 0,005 :5 
Aflinity chromatography 05 
- __ 
0,0’) 
_ 
Gel filtration chromntography 0,04 0.1 I zl 
il.?44 :t2 
2.10 1,350 
One inhibitory unit (1U) is dcfinrxl 11s the amount of inhibitor preparation which toinlly inhibited one activity unii of papain (itself titrated against 
E-64) with one ;lclivity unit rcprcscnting ihc rclcssc of SCIU pmol of NHMcc, 
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mcmbranc-assaciatcd CPI from Mcpa cl 9 arc depicted 
in Table I. Affinity chromatography on a papuin Scpha- 
rose column rcsultcd in a single peak corresponding to 
CPI uctivity (Fig. IA), This affinity step rcsultcd in an 
-SO-fold incrcars in purification of the mcmbranc-usso- 
ciatcd CPI, an increase in purification-fold similar to 
ehue observed previously with soluble cystatins [2.10]. 
The affinity Fractions conttrining CPI ucsivity were 
pooled and subjcctcd SO gel filtration chromasogrlrphy 
(see Section 2). A single peak of CPI activity, rcprcscnt- 
ing a protein of M, I O-1 5 kDu, wus clutcd from the gel 
filswtion column (Fig* 1B). The specific activity of the 
mcmbrznc-associated CPI against pap;lin (Table I) was 
much lower than that of the cytosolic tumor Jtcfins [2j. 
The immunologicrll relationship of the mcmbranc- 
xsociatcd CPf to cyssnsins was dctcrmincd in 
immunoblots using unsibodics to stcfin A, stcfin B, cys- 
tntin C and low-lbf, kininogcn, The mcmbranc-associ- 
utcd CPI did not crodsrwcs with monoclonal ;mtihodicfi 
against cystutin C or at&n B or a polyclonal antibody 
ugninsr low&, kininogcn (Figs. 2 and 3)* Mowcvcr. two 
crossreactive bands, running tit 14 kDu und 70 kDu. 
WCLX detected by a polyclonul antibody to rat cpidcrmal 
stcfin A (Fig. 4). 
Sinsc she mcmbritnc-trasociascd CPI crossrcucscd 
with a stcfin A antibody, WC comptlrcd the isoclcctric 
point of the mcmbrunc-usrociatcd CPl with that of 
human sscfin A by isoclcctric focusing (Fig. 5). The 
control human stcfin A ran t\s several isoforms, the two 
predominant isoforms having pIs of 4,70 and 4.85. The 
predominant isoform of’ the mcmbranc-ossociatcd CPI 
had an isoclcctric point of 4.75. 
A 
. 
-B 97.9 
66,2 
A24 
3! 0 
-‘, 64 1A.A 
123412346 
Fig. 3. lmmunoblot nnalpir of the mcmbranc~r&6ociaKd CPI. The 
ramc blot was anulyzcd squcntiully with polyclonal untibdics lo 
humuncyrtatin C (not illurtrated)und low M, kininogcn(pancl A)end 
u monoclonvl antibody to human uclln B (pm1 U), Ltncs rcprcmt: 
I. purilied mcmbmnc=assesi;tscl CPI from Mcpu cl 9 (4~0); 2 and 3. 
human xtcfin tl (4 /rg and 25 pg. rcspcctivcly); 4.humun rtctin A (1 I 
~0); 5. prcstaincd preein At, rrmdards. 
4. DlSCCJSSION 
The CPI purified from the total membrane fraction 
of the highly invasive murinr hcpatomu, Hcpa cl 9, 
appears to bc a modified form of stcfin A. Two bands 
corresponding to M, 14 and 70 kDa wcrc immunorcac- 
tivc with a stcfin A antibody. yes only a einglc peak 
corresponding to 10-15 kDa on gel filtration had inhib- 
itory activity against papain, In addition, only a single 
isoform of mcmbrnnc CPI could bc rcsolvcd by isctclcc- 
m 21.5 
123456 
Fig. 2. Immunotlot analysis of the mcmhrrnc~asskntcd CPI with a 
monorlonal antibody tlgainrt cystatin C. Lanes rcpt’cscnt: 1, human 
rtcfin A (I 1 JQ): 2 atid 3. human rtcfm 6 (4 pg and 25 yg); 4, purified 
mcmbranc~arsociatcd CPI (4yg); 5, recombinant cystah C (12.5~~) 
opgcuring 3s mulrimcric uggrcgutcr; 6, prcrtuincd protein M, stand- 
nrds. 
21.5 m -- . . 
Ic 
4 
Fig. 4. Immunoblot analysis of the mcmbranc.associatcd CPI wilh a .- ..- --. __. _ A_ c poiycional nniibody against mt cp&tmn~ n1c11n m. Lanzz L~~~MGT: 
I, prcsl;lincd prolcrn M, standards; 2, humun stcfin A (I 1 ~8); 3. 
humun stcfin I3 [4pg): 46. purified mcmbranc~asrociatcd CPI (2 pg. 
4 pg. and 10 pg, rcspcctivcly). 
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Fig, 5, tro~lcctri~ focusing of the mcmbraneossociarccl CPI. lance 
rcprcssnt: I, purified mcmbranc.aworiatcd CPI from flcpe cl 9 (0.12 
rJ: 2. humtin rlclln A ( 0.1 I /ru); 3. Isoclcctric t&wing protein rrand- 
nrdr. Arrows dcpiet rhc poshions of wmplc application. 
tric focusing. Thcrc obscruntions uggest hat ths 70 
kDt1 species of mcmbrnnc CPI muy bc trn irggrcgatc of 
the 14 kDo spccicr. Aggrcgatcs hnvc been reported for 
other cystatins: by ourselves [2] tend others [lo,1 11 for 
stcfin 6 and cystutin C [Lnh, personal communicarion]. 
The immunoblot depicted in Fig. 2 of the prcscnt study 
also illustrates the formation of aggregates by rccombi- 
nant cystatin C In contrast o the mcrnbmnc CPI puri- 
fied from hcptrtoma, the recombinant MU gene product, 
reported by Hiwusa et ot. [6,12,13] to have CPI zcivity. 
is o. mcmbrancassociutcd protein of 21 kDn. Proteins 
with CPI activity in the M, rongc of the rc~ gcnc prod- 
ucts were not dctcctcd in the hcpotoma mcmbroncs. The 
nature of the modificution[s) in stcfin A responsible for 
its association with membranes in the Hcpa cl 9 tumor 
have not been dcrcrmincd. However. a structural alter- 
ation in stcfin A has been suggested to bc responsible 
for the reduced inhibitory capability (increased KJ 
against pupuin rend cathcpsins t3 and L) of s&fin A 
purified from the cytosolis fraction of human $urcoma 
[21. Fossiblc associations of stefin A with the nzcmbmnc 
wcrc not nsscsscd in the previous study, 
The localizocion of protcolytic enzymes with respect 
to their cndogcnous inhibitors as well as the absolute 
lcvcls of protcolytic enzymes and inhibitors appear to 
be criticnl to the ability of tumor cslls to invade through 
b::aemcnt membrane. This is true for cystcint protcasss 
md cystoirh [3] (for review. see iW& OFF metallopro- 
tcms and tissue inhibitors of mctalloprotcoscs (for rc= 
view, scs [15.16]) and for rho plnsminogen activator 
urokinasc and phsminogcn irclivntor inhibieort; (for PC- 
view, see (171), Whcthcr the mcmbmnc-associorcd cys- 
tnrin described hcrc ptoys o role in the invasiveness of 
the Hcpu cl 9 cells will rquirc further study, 
&E;nn~/&r~rrnr~ WC thnnk Mr, Kevin N&on and Dr. Kenneth V. 
Honn (Dcpartmcnt of Radiution Oncology. W~aync Srnrc University, 
Dctroir. MI) far growing the murinc hpntomus used in this rwdy, 
Thlr study was supported by USPHS Grant CA 48210 IO BFS and H 
grant from the Comprchcnriw Cancer Center for Mctrepolitw DC. 
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